Beijing Hotgen Biotech Co., Ltd.
Beijing Hotgen Biotech Co., Ltd.

Precise Protection: Hotgen's Comprehensive Diabetes Diagnosis Solution

Table of Content [Hide]

    Diabetes is a global chronic disease, and early prediction, timely diagnosis, and lifelong monitoring are key to diabetes management. Hotgen provides a comprehensive diabetes diagnostic solution, covering the entire process from diabetes risk prediction to lifelong monitoring, helping clinicians to manage the disease more accurately.


    4-7 Years in Advance: Diabetes Risk Prediction


    By detecting adiponectin (ADP) levels, one can effectively predict an individual's risk of diabetes 4-7 years before its onset. Adiponectin is a protein secreted by adipose tissue, and its reduced levels are closely related to insulin resistance and the development of type 2 diabetes. Hotgen's MQ60 series chemiluminescence immunoassay analyzers provide highly sensitive and specific adiponectin detection, helping clinicians identify high-risk individuals early.


    Diagnosis of Diabetes: Identification of Type 1 Diabetes


    For the precise diagnosis of type 1 diabetes, Hotgen offers a series of autoantibody tests, including:


    • Anti-glutamic acid decarboxylase antibody (GADA)

    • Anti-insulin antibody (IAA)

    • Anti-tyrosine phosphatase antibody (IA-2A)

    • Anti-islet cell antibody (ICA)


    These autoantibodies play important roles in the onset of type 1 diabetes, particularly for the early identification of latent autoimmune diabetes in adults (LADA). IAA appears earlier in younger patients and is an important marker for early screening, while as the disease progresses, the positivity rates of GADA, IA-2A, and ICA gradually increase.


    Lifelong Monitoring: Diabetes Treatment Monitoring


    The management of diabetes is inseparable from long-term blood glucose monitoring. Hotgen's CLIA instrument can perform HbA1c detection, providing important evidence for blood glucose control in diabetes patients.


    Clinical Value of HbA1c

    HbA1c is a product of the combination of hemoglobin and blood glucose, reflecting a patient's average blood glucose level over the past 2 to 3 months. Its clinical significance includes:

    • Diagnosis of diabetes and pre-diabetes: HbA1c testing is widely used for screening and diagnosing diabetes, especially convenient for patients who cannot undergo fasting blood glucose testing.

    • Treatment monitoring and efficacy evaluation: By monitoring HbA1c levels, doctors can assess the patient's blood glucose control and adjust treatment plans accordingly.

    • Complication risk assessment: HbA1c levels are closely related to macrovascular and microvascular complications associated with diabetes and are important indicators for predicting complication risks.


    Advantages of HbA1c Testing


    • Low biological variability, stable and reliable results;

    • Reflects overall blood glucose exposure level, highly comprehensive;

    • Internationally standardized, facilitating result comparison;

    • No need for fasting or specific sampling times;

    • Not easily influenced by acute stress factors;

    • Can directly guide and adjust diabetes treatment plans.


    Hotgen Chemiluminescence Immunoassay Analyzers: Efficient and Accurate Detection Platform


    Hotgen's MQ60 chemiluminescence immunoassay analyzer provides strong support for early diagnosis and monitoring of diabetes. The instrument features high-throughput detection capabilities and supports single-item testing, ensuring flexibility and efficiency in detection. Currently, Hotgen's chemiluminescence immunoassay platform covers over 110 detection parameters, including cardiovascular diseases, inflammation, cancer, hormone-related diseases, diabetes, and rheumatoid arthritis. In the future, Hotgen will continue to expand its detection projects, providing more comprehensive disease detection solutions for clinical use.


    Conclusion


    Hotgen's comprehensive diabetes diagnostic solution integrates diabetes risk prediction, precise diagnosis, and lifelong monitoring. Leveraging advanced chemiluminescence immunoassay technology, it provides efficient and accurate testing services for clinicians and patients. As a professional CLIA analyzer manufacturer, whether it's early identification of high-risk individuals, diagnosing type 1 diabetes, or long-term blood glucose control monitoring, Hotgen is dedicated to providing full support for diabetes management. Choose Hotgen, and choose a more scientific diabetes management solution.

    References
    Products
    Hotgen Updates